Sinovac Biotech (($SVA)) announced an update on their ongoing clinical study. Sinovac Biotech is conducting a Phase III clinical trial titled ...
Sinovac Biotech (($SVA)) announced an update on their ongoing clinical study. Sinovac Biotech is conducting a Phase III clinical trial titled ...
SAO PAULO, Nov 26 (Reuters) - Sao Paulo could roll out a COVID-19 vaccine developed by China's Sinovac without approval from the national health regulator, Governor Joao Doria said in an interview on ...
The Board of Directors and Management of SINOVAC Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the Audit ...
SAO PAULO, Oct 2 (Reuters) - The government of Sao Paulo state in Brazil has asked health regulator Anvisa to register for use the COVID-19 vaccine candidate developed by China's Sinovac Biotech Ltd ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback